Re: Tandem vs single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis.
Giralt
Sergio
S
Vesole
David H
DH
Somlo
George
G
Krishnan
Amrita
A
Stadtmauer
Edward
E
Mccarthy
Philip
P
Pasquini
Marcelo C
MC
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001897:Boronic Acids / Q000008:administration & dosage; D000069286:Bortezomib; D018572:Disease-Free Survival; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods; D006801:Humans; D000077269:Lenalidomide; D015201:Meta-Analysis as Topic; D009101:Multiple Myeloma / Q000401:mortality* / Q000601:surgery*; D011719:Pyrazines / Q000008:administration & dosage; D012107:Research Design; D016879:Salvage Therapy / Q000379:methods; D016019:Survival Analysis; D013792:Thalidomide / Q000008:administration & dosage / Q000031:analogs & derivatives; D014182:Transplantation, Autologous
D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D013792:Thalidomide; D000069286:Bortezomib; D000077269:Lenalidomide